The UC Narrative is a global initiative created by Pfizer to engage the UC community to help identify how people living with ulcerative colitis are impacted by the disease. The U.S. survey findings represent a subset of the UC Narrative global survey, which was developed with input from the Global UC Narrative Advisory Panel.
The Global UC Narrative Advisory Panel, 1 comprised of people living with UC, as well as leading gastroenterologists, IBD nurses, a psychologist, and patient organizations, including the Crohn’s & Colitis Foundation in the U.S., from 10 countries will work together to turn the insights gleaned from the survey into actions that can help identify real-world needs and concerns about living with UC.
For the U.S. survey, a total of 301 U.S. UC adult patients were surveyed online or by telephone between August and October 2017. Patients self-reported that they had been diagnosed with UC and had their diagnosis confirmed by an endoscopic procedure, did not have a colectomy, had visited a GI office in the past 12 months and had taken prescription medication for their UC; patients who reported taking only 5-ASA (5-aminosalicylic acid) medications were excluded. A total of 149 U.S. gastroenterologists were surveyed online between August and November 2017. To qualify for participation, physicians must have seen at least 10 UC patients per month, with at least 10 percent of those patients currently taking a biologic treatment for UC. Patients and physicians who qualified for and successfully completed the survey were compensated for their participation.
1Where permitted, members of the Global UC Narrative Advisory Panel were paid honoraria for their participation.
To learn more: https://www.pfizer.com/news/press-kits/uc-narrative
Breast Cancer: A Story Half Told is an initiative by Pfizer in partnership with advocates, patients and healthcare professionals that aims to elevate public understanding of metastatic breast cancer, dispel misperceptions, combat stigma and expand the breast cancer conversation to be more inclusive of metastatic breast cancer. The unbranded campaign focuses on metastatic breast cancer patients in their daily lives at home, at work, at play or at the doctor’s office. The goal was to create socially engaging content rooted in honest storytelling.
In this video, Beth Fairchild, shares where she draws strength as a mother, wife and woman living with metastatic breast cancer. This video and others others provide deep insight into the lives, worries, hopes and dreams of metastatic breast cancer patients.
For a look behind the scenes with Beth Fairchild, view our gallery.
Esther is a 55-year-old mother, grandmother, metastatic breast cancer patient and advocate within the Latina breast cancer community. Esther brings her story to the mbc awareness campaign Story Half Told. We had the honor of working with Esther and her family and friends to shed light on her personal story.
Breast Cancer: A Story Half Told is the initiative by Pfizer in partnership with advocates, patients and healthcare professionals that aims to elevate public understanding of metastatic breast cancer, dispel misperceptions, combat stigma and expand the breast cancer conversation to be more inclusive of metastatic breast cancer. The unbranded campaign focuses on metastatic breast cancer patients in their daily lives at home, at work, at play or at the doctor’s office. The goal was to create socially engaging content rooted in honest storytelling.
Story Half Told was nominated for a 2016 Cannes Lion and 2016 Sabre Award.
Life Sciences Pennsylvania (LSPA), formerly Pennsylvania Bio, has reinvented itself to better reflect its diverse and growing members. We worked with Tonic Life Communications on the creation of this rebrand launch video to celebrate the organizations history and promise.
LSPA delivers two valuable services – public policy clout and strategic connections that can advance you and your organization. Our public policy work in both Harrisburg and Washington ensures that all of our members are heard by those who make legislative decisions.
Life Sciences Pennsylvania provides members with unparalleled networking opportunities to facilitate strategic connections. Our array of both large and small events throughout the year and the strategic group buying program, ensure that our members stay connected 365-24-7.
Working with Novartis Oncology and Cohn & Wolfe, we created a series of animations explaining Advanced Melanoma.
Melanoma is a type of skin cancer most commonly caused by damage to the DNA in a certain type of skin cells called melanocytes, often due to exposure to ultraviolet light. This damage can cause skin cells to form cancerous tumors, but if caught early it is almost always curable. However, if left untreated, melanoma can spread, or metastasize, to other parts of the body. This animation video provides additional details about advanced melanoma.
© 2016 Novartis AG